Format

Send to

Choose Destination
Proteomics. 2008 Nov;8(21):4370-82. doi: 10.1002/pmic.200800051.

Phosphoproteomics, oncogenic signaling and cancer research.

Author information

1
Oncology Research Institute, Yong Loo Lin School of Medicine, Singapore.

Abstract

The past 5 years have seen an explosion of phosphoproteomics methods development. In this review, using epidermal growth-factor signaling as a model, we will discuss how phosphoproteomics, along with bioinformatics and computational modeling, have impacted key aspects of oncogenic signaling such as in the temporal fine mapping of phosphorylation events, and the identification of novel tyrosine kinase substrates and phosphorylation sites. We submit that the next decade will see considerable exploitation of phosphoproteomics in cancer research. Such a phenomenon is already happening as exemplified by its use in promoting the understanding of the molecular etiology of cancer and target-directed therapeutics.

PMID:
18814326
DOI:
10.1002/pmic.200800051
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center